Retrospective analysis in 46 women with vulvovaginal atrophy treated with ospemifene for 12 weeks: improvement in overactive bladder symptoms-Reference-Cited by-同舟云学术

Retrospective analysis in 46 women with vulvovaginal atrophy treated with ospemifene for 12 weeks: improvement in overactive bladder symptoms

Published:2017-05-11 Issue:12 Volume:33 Page:942-945
ISSN:0951-3590
Container-title:Gynecological Endocrinology
language:en
Short-container-title:Gynecological Endocrinology

Author:

Schiavi Michele Carlo¹,Zullo Marzio Angelo²,Faiano Pierangelo¹,D’Oria Ottavia¹,Prata Giovanni¹,Colagiovanni Vanessa¹,Giannini Andrea¹,Di Tucci Chiara¹,Perniola Giorgia¹,Di Donato Violante¹,Monti Marco¹,Muzii Ludovico¹,Benedetti Panici Pierluigi¹

Affiliation:

1. Department of Gynecological and Obstetric Sciences, and Urological Sciences, University of Rome “Sapienza”, Umberto I Hospital, Rome, Italy and

2. Department of Surgery-Week Surgery, Campus Biomedico, University of Rome, Rome, Italy

Publisher

Informa UK Limited

Subject

Obstetrics and Gynaecology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.1080/09513590.2017.1323859

Reference31 articles.

1. Combined Vaginal Pelvic Floor Electrical Stimulation (PFS) and Local Vaginal Estrogen for Treatment of Overactive Bladder (OAB) in Perimenopausal Females. Randomized Controlled Trial (RCT)

2. Oestrogens and overactive bladder